Vista, Air NZ surge on vaccine hopes

Vista, Air NZ surge on vaccine hopes
Dan Brunskill
New Zealand stocks hardest hit by the covid-19 pandemic registered double-digit gains after drugmakers Pfizer and BioNTech said their prospective vaccine was more than 90 percent effective in a trial.Stocks on Wall Street - already enjoying the Biden Bounce - rallied further on reports that preliminary data from a 44,000-volunteer study showed 90 percent participants who received the drug had fewer cases of symptomatic covid-19 than those who received a placebo.Safety data will not be available until later this month and Pfizer and BioNTech hav...

More Markets

Fletcher dodges product recall in upbeat end to August for NZX 50
Markets

Fletcher dodges product recall in upbeat end to August for NZX 50

The S&P/NZX 50 Index rose 97.07 points, or 0.8%, to 12,447.68.

Paul McBeth 30 Aug 2024
Fletcher Building expects $168m hit from leaky pipes response
Markets

Fletcher Building expects $168m hit from leaky pipes response

Fletcher Building subsidiary Iplex Australia to cover 80% of repair costs.

John Anthony 30 Aug 2024
Ritchies posts $17m annual net loss
Markets

Ritchies posts $17m annual net loss

The bus operator's net loss widened from $8m to $17m in the year to March 31.

John Anthony 30 Aug 2024
Fletcher shares in trading halt as leaky pipes announcement looms
Markets

Fletcher shares in trading halt as leaky pipes announcement looms

Fletcher Building is awaiting an announcement from the Government of Western Australia.

John Anthony 30 Aug 2024